We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors

News   Jan 30, 2018 | Original story from Metrion Biosciences

 
Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors

Credit: Metrion Biosciences

 
 
 

RELATED ARTICLES

Common Disease Mechanism for ALS and Frontotemporal Dementia

News

Findings suggest mutations leading to accumulation of RNA-binding proteins to blame for disease, and could offer route for early diagnosis

READ MORE

Misery Loves Company -for Teens

News

Study on adolescent friendships offers support for the belief that misery really does love company.

READ MORE

Scientists Discover Intricacies of Serotonin Receptor Crucial for Better Drugs

News

Researchers have figured out precisely why one drug binds to the serotonin receptor 5-HT2BR and activates it to cause heart problems while very similar drugs do not. They've also discovered why a third drug acts like a 5-HT2BR antagonist - it blocks the receptor's activity - while the very well-known similar hallucinogenic drug LSD does not.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE